Xpovio  (selinexor)

pCPA File Number: 21962
Negotiation Status:
Under consideration for negotiation
Indication(s):
For the treatment of adult patients, in combination with bortezomib (V) and dexamethasone (d), with multiple myeloma (MM) who have received at least one prior therapy.
Sponsor/Manufacturer:
Forus Therapeutics Inc.
CADTH Project Number:
PC0276
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable